The global lysosomal storage disease treatment market, valued at USD 4.50 billion in 2024, is poised to expand steadily over the next decade. With a compound annual growth rate (CAGR) of 4.2% from 2025 to 2034, the market is projected to reach USD 6.80 billion by 2034, according to recent industry analysis. This growth is fueled by increasing diagnosis rates, the rise...